Microvascular Coronary Dysfunction in Women-Pathophysiology, Diagnosis, and Management

Current Problems in Cardiology

Volumn 36, Issue 8, 2011, Pages 291-318

  Kothawade, Kamlesh ^a   Bairey Merz, C Noel ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ADENOSINE; AMITRIPTYLINE; ANGIOTENSIN RECEPTOR ANTAGONIST; ARGININE; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLYCERYL TRINITRATE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMIPRAMINE; NITRATE; RANOLAZINE; XANTHINE DERIVATIVE; ANTITHROMBOCYTIC AGENT; VASODILATOR AGENT;

AGING; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; AUTONOMIC NEUROPATHY; BLOOD RHEOLOGY; BLOOD VISCOSITY; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR SYSTEM EXAMINATION; CAUSE OF DEATH; CLINICAL EVALUATION; CONGESTIVE HEART FAILURE; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY CONSTRICTION; CORONARY ARTERY DILATATION; CORONARY ARTERY DISEASE; CORONARY FLOW RESERVE; CORONARY REACTIVITY TESTING; CORONARY VASCULAR RESISTANCE; COUNTERPULSATION; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; ENDOTHELIAL DYSFUNCTION; ENHANCED EXTERNAL COUNTERPULSATION; FEMALE; GOLD STANDARD; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HUMAN; INFLAMMATION; LIFESTYLE MODIFICATION; LOW DRUG DOSE; MICROANGIOPATHY; MICROCIRCULATION; MICROVASCULAR CORONARY DYSFUNCTION; MICROVASCULARIZATION; NON INVASIVE PROCEDURE; PATHOPHYSIOLOGY; PRINZMETAL ANGINA PECTORIS; PROGNOSIS; SEX DIFFERENCE; STROKE; SYNDROME X; SYSTEMIC DISEASE; THORAX PAIN; TREADMILL EXERCISE; BLOOD FLOW VELOCITY; CORONARY BLOOD VESSEL; PATHOLOGY; PHYSIOLOGY; REVIEW; VASCULAR ENDOTHELIUM; VASODILATATION; WOMEN'S HEALTH;

BLOOD FLOW VELOCITY; CORONARY CIRCULATION; CORONARY VESSELS; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; MICROCIRCULATION; MICROVASCULAR ANGINA; NITROGLYCERIN; PLATELET AGGREGATION INHIBITORS; PROGNOSIS; VASODILATION; VASODILATOR AGENTS; WOMEN'S HEALTH;

EID: 79959690297     PISSN: 01462806     EISSN: 15356280     Source Type: Journal    
DOI: 10.1016/j.cpcardiol.2011.05.002     Document Type: Article

References (112)

1. Reis S.E., Holubkov R., Conrad Smith A.J., et al. Coronary microvascular dysfunction is highly prevalent in women with chest pain in the absence of coronary artery disease: Results from the NHLBI WISE study. Am Heart J 2001, 141:735-741.
2. Diver D.J., Bier J.D., Ferreira P.E., et al. Clinical and arteriographic characterization of patients with unstable angina without critical coronary arterial narrowing (from the TIMI-IIIA Trial). Am J Cardiol 1994, 74:531-537.
3. Noel B., Merz C., Eteiba W., et al. Cardiac syndrome X: Relation to microvascular angina and other conditions. Curr Cadiovsc Risks Rep 2007, 1:167-175.
4. Sharaf B.L., Pepine C.J., Kerensky R.A., et al. Detailed angiographic analysis of women with suspected ischemic chest pain (pilot phase data from the NHLBI-sponsored women's ischemia Syndrome Evaluation [WISE] study angiographic core laboratory). Am J Cardiol 2001, 87:937-941.
5. Kaski J.C., Rosano G.M., Collins P., et al. Cardiac syndrome X: clinical characteristics and left ventricular function. Long-term follow-up study. J Am Coll Cardiol 1995, 25:807-814.
6. Lichtlen P.R., Bargheer K., Wenzlaff P. Long-term prognosis of patients with anginalike chest pain and normal coronary angiographic findings. J Am Coll Cardiol 1995, 25:1013-1018.
7. Reis S.E., Holubkov R., Smith A., et al. Coronary microvascular dysfunction is highly prevalent in women with chest pain in the absence of coronary artery disease: Results from the NHLBI WISE study. Am Heart J 2001, 141:735-741.
8. Beltrame J.F., Crea F., Camici P. Advances in coronary microvascular dysfunction. Heart Lung Circ 2009, 18:19-27.
9. Camici P.G., Crea F. Coronary microvascular dysfunction. N Engl J Med 2007, 356:830-840.
10. Reis S.E., Holubkov R., Lee J.S., et al. Coronary flow velocity response to adenosine characterizes coronary microvascular function in women with chest pain and no obstructive coronary disease: Results from the pilot phase of the Women's Ischemia Syndrome Evaluation (WISE) Study. J Am Coll Cardiol 1999, 33:1469-1475.
11. Panza J.A. Coronary atherosclerosis: extending to the microcirculation?. Eur Heart J 2010, 31:905-907.
12. Mosseri M., Yarom R., Gotsman M.S., et al. Histologic evidence for small-vessel coronary artery disease in patients with angina pectoris and patent large coronary arteries. Circulation 1986, 74:964-972.
13. Lanza G.A., Crea F. Primary coronary microvascular dysfunction: clinical presentation, pathophysiology, and management. Circulation 2010, 121:2317-2325.
14. Erbel A., Ge J., Bockischt A., et al. Value of intracoronary ultrasound and Doppler in the differentiation of angiographically normal coronary arteries: a prospective study in patients with angina pectoris. Eur Heart J 1996, 17:880-889.
15. Zeiher A.M., Drexler H., Wollschlaeger H., et al. Coronary vasomotion in response to sympathetic stimulation in humans: Importance of the functional integrity of the endothelium. J Am Coll Cardiol 1989, 14:1181-1190.
16. Hasdai D., Cannan C.R., Mathew V., et al. Evaluation of patients with minimally obstructive coronary artery disease and angina. Int J Cardiol 1996, 53:203-208.
17. Hori M., Kitakaze M. Adenosine, the heart, and coronary circulation. Hypertension 1991, 18:565-574.
18. Marcus M.L., Chilian W.M., Kanatsuka H., et al. Understanding the coronary circulation through studies at the microvascular level. Circulation 1990, 82:1-7.
19. Kansra U., Sircar S. Microvascular Angina. J Indian Acad Clin Med 2001, 2:67-72.
20. Kemp H.G., Vokonas P.S., Cohn P.F., et al. The anginal syndrome associated with normal coronary arteriograms. Report of a six year experience. Am J Med 1973, 54:735-742.
21. Kaski J.C., Crea F., Nihoyannopoulos P., et al. Transient myocardial ischemia during daily life in patients with syndrome X. Am J Cardiol 1986, 58:1242-1247.
22. Cannon R.O., Camici P.G., Epstein S.E. Pathophysiological dilemma of syndrome X. Circulation 1992, 85:883-892.
23. Cannon R.O., Watson R.M., Rosing D.R., et al. Angina caused by reduced vasodilator reserve of the small coronary arteries. J Am Coll Cardiol 1983, 1:1359-1373.
24. Cannon R.O., Epstein S.E. "Microvascular angina" as a cause of chest pain with angiographically normal coronary arteries. Am J Cardiol 1988, 61:1338-1343.
25. Panza J.A., Laurienzo J.M., Curiel R.V., et al. Investigation of the mechanism of chest pain in patients with angiographically normal coronary arteries using transesophageal dobutamine stress echocardiography. J Am Coll Cardiol 1997, 29:293-301.
26. Camici P.G., Marraccini P., Lorenzoni R., et al. Coronary hemodynamics and myocardial metabolism in patients with syndrome X: Response to pacing stress. J Am Coll Cardiol 1991, 17:1461-1470.
27. Nihoyannopoulos P., Carlos Kaski J., Crake T., et al. Absence of myocardial dysfunction during stress in patients with syndrome X. J Am Coll Cardiol 1991, 18:1463-1470.
28. Rosen S.D., Uren N.G., Kaski J.C., et al. Coronary vasodilator reserve, pain perception, and sex in patients with syndrome X. Circulation 1994, 90:50-60.
29. Camici P.G., Gistri R., Lorenzoni R., et al. Coronary reserve and exercise ECG in patients with chest pain and normal coronary angiograms. Circulation 1992, 86:179-186.
30. Lanza G.A., Buffon A., Sestito A., et al. Relation between stress-induced myocardial perfusion defects on cardiovascular magnetic resonance and coronary microvascular dysfunction in patients with cardiac syndrome X. J Am Coll Cardiol 2008, 51:466-472.
31. Chauhan A., Mullins P.A., Taylor G., et al. Both endothelium-dependent and endothelium-independent function is impaired in patients with angina pectoris and normal coronary angiograms. Eur Heart J 1997, 18:60-68.
32. Bøttcher M., Botker H.E., Sonne H., et al. Endothelium-dependent and -independent perfusion reserve and the effect of l-arginine on myocardial perfusion in patients with syndrome X. Circulation 1999, 99:1795-1801.
33. Galassi A.R., Crea F., Araujo L.I., et al. Comparison of regional myocardial blood flow in syndrome X and one-vessel coronary artery disease. Am J Cardiol 1993, 72:134-139.
34. Meeder J.G., Blanksma P.K., Crijns H.J., et al. Mechanisms of angina pectoris in syndrome X assessed by myocardial perfusion dynamics and heart rate variability. Eur Heart J 1995, 16:1571-1577.
35. Timmis A.D., Lawson C.S., Tweddel A.C. Thallium scans in syndrome X. Br Heart J 1992, 68:636.
36. Motz W., Vogt M., Rabenau O., et al. Evidence of endothelial dysfunction in coronary resistance vessels in patients with angina pectoris and normal coronary angiograms. Am J Cardiol 1991, 68:996-1003.
37. Panting J.R., Gatehouse P.D., Yang G., et al. Abnormal subendocardial perfusion in cardiac syndrome X detected by cardiovascular magnetic resonance imaging. N Engl J Med 2002, 346:1948-1953.
38. Rosen S.D., Paulesu E., Wise R.J., et al. Central neural contribution to the perception of chest pain in cardiac syndrome X. Heart 2002, 87:513-519.
39. Crea F., Lanza G.A. Angina pectoris and normal coronary arteries: cardiac syndrome X. Heart 2004, 90:457-463.
40. Kaski J.C. Pathophysiology and management of patients with chest pain and normal coronary arteriograms (cardiac syndrome X). Circulation 2004, 109:568-572.
41. Drexler H., Zeiher A.M., Wollschläger H., et al. Flow-dependent coronary artery dilatation in humans. Circulation 1989, 80:466-474.
42. Roman M.J., Naqvi T.Z., Gardin J.M., et al. Clinical application of noninvasive vascular ultrasound in cardiovascular risk stratification: a report from the American Society of Echocardiography and the Society of Vascular Medicine and Biology. J Am Soc Echocardiogr 2006, 19:943-954.
43. Quyyumi A.A. Endothelial function in health and disease: new insights into the genesis of cardiovascular disease. Am J Med 1998, 105:32S-39S.
44. Sodha N.R., Boodhwani M., Clements R.T., et al. Coronary microvascular dysfunction in the setting of chronic ischemia is independent of arginase activity. Microvasc Res 2008, 75:238-246.
45. Drexler H., Hornig B. Endothelial dysfunction in human disease. J Mol Cell Cardiol 1999, 31:51-60.
46. Bugiardini R., Badimon L., Collins P., et al. Angina, "normal" coronary angiography, and vascular dysfunction: risk assessment strategies. PLoS Med 2007, 4:e12.
47. Hasdai D., Gibbons R.J., Holmes D.R., et al. Coronary endothelial dysfunction in humans is associated with myocardial perfusion defects. Circulation 1997, 96:3390-3395.
48. von Mering G.O., Arant C.B., Wessel T.R., et al. Abnormal coronary vasomotion as a prognostic indicator of cardiovascular events in women: results from the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE). Circulation 2004, 109:722-725.
49. Halcox J.P., Schenke W.H., Zalos G., et al. Prognostic value of coronary vascular endothelial dysfunction. Circulation 2002, 106:653-658.
50. Lanza G.A., Giordano A., Pristipino C., et al. Abnormal cardiac adrenergic nerve function in patients with syndrome X detected by [123I]metaiodobenzylguanidine myocardial scintigraphy. Circulation 1997, 96:821-826.
51. Frøbert O., Mølgaard H., Bøtker H.E., et al. Autonomic balance in patients with angina and a normal coronary angiogram. Eur Heart J 1995, 16:1356-1360.
52. Adamopoulos S., Rosano G.M., Ponikowski P., et al. Impaired baroreflex sensitivity and sympathovagal balance in syndrome X. Am J Cardiol 1998, 82:862-868.
53. Gulli G., Cemin R., Pancera P., et al. Evidence of parasympathetic impairment in some patients with cardiac syndrome X. Cardiovasc Res 2001, 52:208-216.
54. Kaski J.C., Cox I.D., Crook J., et al. Differential plasma endothelin levels in subgroups of patients with angina and angiographically normal coronary arteries. Am Heart J 1998, 136:412-417.
55. Jayaweera A.R., Wei K., Coggins M., et al. Role of capillaries in determining CBF reserve: new insights using myocardial contrast echocardiography. Am J Physiol Heart Circ Physiol 1999, 277:H2363-H2372.
56. Kaul S., Jayaweera A.R. Myocardial capillaries and coronary flow reserve. J Am Coll Cardiol 2008, 52:1399-1401.
57. Pepine C.J., Kerensky R.A., Lambert C.R., et al. Some thoughts on the vasculopathy of women with ischemic heart disease. J Am Coll Cardiol 2006, 47:S30-S35.
58. Sun H., Mohri M., Shimokawa H., et al. Coronary microvascular spasm causes myocardial ischemia in patients with vasospastic angina. J Am Coll Cardiol 2002, 39:847-851.
59. Lanza G.A., Sestito A., Cammarota G., et al. Assessment of systemic inflammation and infective pathogen burden in patients with cardiac syndrome X. Am J Cardiol 2004, 94:40-44.
60. Tomai F., Ribichini F., Ghini A.S., et al. Elevated C-reactive protein levels and coronary microvascular dysfunction in patients with coronary artery disease. Eur Heart J 2005, 26:2099-2105.
61. Pavlov V.A., Tracey K.J. The cholinergic anti-inflammatory pathway. Brain Behav Immun 2005, 19:493-499.
62. Egashira K., Inou T., Hirooka Y., et al. Effects of age on endothelium-dependent vasodilation of resistance coronary artery by acetylcholine in humans. Circulation 1993, 88:77-81.
63. Celermajer D.S., Sorensen K.E., Spiegelhalter D.J., et al. Aging is associated with endothelial dysfunction in healthy men years before the age-related decline in women. J Am Coll Cardiol 1994, 24:471-476.
64. Chauhan A., More R.S., Mullins P.A., et al. Aging-associated endothelial dysfunction in humans is reversed by L-arginine. J Am Coll Cardiol 1996, 28:1796-1804.
65. Moritoki H., Yoshikawa T., Hisayama T., et al. Possible mechanisms of age-associated reduction of vascular relaxation caused by atrial natriuretic peptide. Eur J Pharmacol 1992, 210:61-68.
66. Hogan J.C., Lewis M.J., Henderson A.H. In vivo EDRF activity influences platelet function. Br J Pharmacol 1988, 94:1020-1022.
67. Olivotto I., Cecchi F., Camici P.G. Coronary microvascular dysfunction and ischemia in hypertrophic cardiomyopathy. Mechanisms and clinical consequences. Ital Heart J 2004, 5:572-580.
68. Neglia D., Parodi O., Gallopin M., et al. Myocardial blood flow response to pacing tachycardia and to dipyridamole infusion in patients with dilated cardiomyopathy without overt heart failure. A quantitative assessment by positron emission tomography. Circulation 1995, 92:796-804.
69. Marcus M.L., Harrison D.G., Chilian W.M., et al. Alterations in the coronary circulation in hypertrophied ventricles. Circulation 1987, 75(1 Pt 2):I19-I25.
70. Brush J.E., Cannon R.O., Schenke W.H., et al. Angina due to coronary microvascular disease in hypertensive patients without left ventricular hypertrophy. N Engl J Med 1988, 319:1302-1307.
71. Opherk D., Mall G., Zebe H., et al. Reduction of coronary reserve: a mechanism for angina pectoris in patients with arterial hypertension and normal coronary arteries. Circulation 1984, 69:1-7.
72. Yokoyama I., Murakami T., Ohtake T., et al. Reduced coronary flow reserve in familial hypercholesterolemia. J Nucl Med 1996, 37:1937-1942.
73. Uren N.G., Crake T., Lefroy D.C., et al. Delayed recovery of coronary resistive vessel function after coronary angioplasty. J Am Coll Cardiol 1993, 21:612-621.
74. el-Tamimi H., Davies G.J., Sritara P., et al. Inappropriate constriction of small coronary vessels as a possible cause of a positive exercise test early after successful coronary angioplasty. Circulation 1991, 84:2307-2312.
75. Elliott P.M., Kindler H., Shah J.S., et al. Coronary microvascular dysfunction in male patients with Anderson-Fabry disease and the effect of treatment with alpha galactosidase A. Heart 2006, 92:357-360.
76. Kalani M. The importance of endothelin-1 for microvascular dysfunction in diabetes. Vasc Health Risk Manag 2008, 4:1061-1068.
77. Di Carli M.F., Janisse J., Grunberger G., et al. Role of chronic hyperglycemia in the pathogenesis of coronary microvascular dysfunction in diabetes. J Am Coll Cardiol 2003, 41:1387-1393.
78. Shivu G.N., Phan T., Abozguia K., et al. Relationship between coronary microvascular dysfunction and cardiac energetics impairment in type 1 diabetes mellitus. Circulation 2010, 121:1209-1215.
79. Kaski J.C., Valenzuela Garcia L.F. Therapeutic options for the management of patients with cardiac syndrome X. Eur Heart J 2001, 22:283-293.
80. Hurst T., Olson T.H., Olson L.E., et al. Cardiac syndrome X and endothelial dysfunction: new concepts in prognosis and treatment. Am J Med 2006, 119:560-566.
81. Gould K.L., Lipscomb K., Hamilton G.W. Physiologic basis for assessing critical coronary stenosis. Instantaneous flow response and regional distribution during coronary hyperemia as measures of coronary flow reserve. Am J Cardiol 1974, 33:87-94.
82. Uren N.G., Melin J.A., De Bruyne B., et al. Relation between myocardial blood flow and the severity of coronary-artery stenosis. N Engl J Med 1994, 330:1782-1788.
83. Handberg E., Johnson B.D., Arant C.B., et al. Impaired coronary vascular reactivity and functional capacity in women: results from the NHLBI Women's Ischemia Syndrome Evaluation (WISE) Study. J Am Coll Cardiol 2006, 47(Suppl 3):S44-S49.
84. Aarnoudse W., van't Veer M., Pijls N.H., et al. Direct volumetric blood flow measurement in coronary arteries by thermodilution. J Am Coll Cardiol 2007, 50:2294-2304.
85. Gibson C.M., Cannon C.P., Daley W.L., et al. TIMI frame count: a quantitative method of assessing coronary artery flow. Circulation 1996, 93:879-888.
86. Kirschbaum S., Van Geuns R. Cardiac magnetic resonance imaging to detect and evaluate ischemic heart disease. Hellenic J Cardiol 2009, 50:119-126.
87. Nekolla S., Reder S., Saraste A., et al. Evaluation of the novel myocardial perfusion positron-emission tomography tracer 18F-BMS-747158-02: comparison to 13N-ammonia and validation with microspheres in a pig model. Circulation 2009, 119:2333-2342.
88. Nicol E.D., Stirrup J., Reyes E., et al. Sixty-four-slice computed tomography coronary angiography compared with myocardial perfusion scintigraphy for the diagnosis of functionally significant coronary stenoses in patients with a low to intermediate likelihood of coronary artery disease. J Nucl Cardiol 2008, 15:311-318.
89. Carr C., Lindner J. Myocardial perfusion imaging with contrast echocardiography. Curr Cardiol Rep 2008, 10:233-239.
90. Hudsmith L.E., Neubauer S. Magnetic resonance spectroscopy in myocardial disease. J Am Coll Cardiol Imaging 2009, 2:87-96.
91. Rigo F., Cortigiani L., Gherardi S., et al. Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy: a Doppler echocardiography study. Circulation 2007, 116. (16 Meeting Abstracts):II369-c.
92. Bugiardini R., Bairey Merz C.N. Angina with "normal" coronary arteries: a changing philosophy. JAMA 2005, 293:477-484.
93. Johnson B.D., Shaw L.J., Buchthal S.D., et al. Prognosis in women with myocardial ischemia in the absence of obstructive coronary disease: results from the National Institutes of Health-National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE). Circulation 2004, 109:2993-2999.
94. Pepine C.J., Anderson R.D., Sharaf B.L., et al. Coronary microvascular reactivity to adenosine predicts adverse outcome in women evaluated for suspected ischemia: results from the National Heart, Lung and Blood Institute WISE (Women's Ischemia Syndrome Evaluation) Study. J Am Coll Cardiol 2010, 55:2825-2832.
95. Eriksson B.E., Tyni-Lennè R., Svedenhag J., et al. Physical training in syndrome X: physical training counteracts deconditioning and pain in syndrome X. J Am Coll Cardiol 2000, 36:1619-1625.
96. Bonetti P.O., Lerman L.O., Lerman A. Endothelial dysfunction: a marker of atherosclerotic risk. Arterioscler Thromb Vasc Biol 2003, 23:168-175.
97. Hinoi T., Tomohiro Y., Kajiwara S., et al. Telmisartan, an angiotensin II type 1 receptor blocker, improves coronary microcirculation and insulin resistance among essential hypertensive patients without left ventricular hypertrophy. Hypertens Res 2008, 31:615-622.
98. Tiefenbacher C.P., Friedrich S., Bleeke T., et al. ACE inhibitors and statins acutely improve endothelial dysfunction of human coronary arterioles. Am J Physiol Heart Circ Physiol 2004, 286:H1425-H1432.
99. Lanza G.A., Colonna G., Pasceri V., et al. Atenolol versus amlodipine versus isosorbide-5-mononitrate on anginal symptoms in syndrome X. Am J Cardiol 1999, 84:A8. (854-856).
100. Anderson J.L., Adams C.D., Antman E.M., et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients with Unstable Angina/Non ST-Elevation Myocardial Infarction): developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons: endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. Circulation 2007, 116:e148-e304.
101. Palloshi A., Fragasso G., Piatti P., et al. Effect of oral L-arginine on blood pressure and symptoms and endothelial function in patients with systemic hypertension, positive exercise tests, and normal coronary arteries. Am J Cardiol 2004, 93:933-935.
102. Dzavík V., Cotter G., Reynolds H.R., et al. Effect of nitric oxide synthase inhibition on haemodynamics and outcome of patients with persistent cardiogenic shock complicating acute myocardial infarction: a phase II dose-ranging study. Eur Heart J 2007, 28:1109-1116.
103. Chaitman B.R. Ranolazine for the treatment of chronic angina and potential use in other cardiovascular conditions. Circulation 2006, 113:2462-2472.
104. Mehta P.K., Goykhman P., Thomson L.E., et al. Ranolazine improves angina in women with evidence of ischemia but no obstructive coronary artery disease: a pilot, randomized-controlled trial. Circulation 2010, 122:A16283. (21 Meeting Abstracts).
105. Emdin M., Picano E., Lattanzi F., et al. Improved exercise capacity with acute aminophylline administration in patients with syndrome X. J Am Coll Cardiol 1989, 14:1450-1453.
106. Chen J.W., Lee W.L., Hsu N.W., et al. Effects of short-term treatment of nicorandil on exercise-induced myocardial ischemia and abnormal cardiac autonomic activity in microvascular angina. Am J Cardiol 1997, 80:32-38.
107. Vicari R.M., Chaitman B., Keefe D., et al. Efficacy and safety of fasudil in patients with stable angina: a double-blind, placebo-controlled, phase 2 trial. J Am Coll Cardiol 2005, 46:1803-1811.
108. Cannon R.O., Quyyumi A.A., Mincemoyer R., et al. Imipramine in patients with chest pain despite normal coronary angiograms. N Engl J Med 1994, 330:1411-1417.
109. Mayou R.A., Bryant B.M., Sanders D., et al. A controlled trial of cognitive behavioural therapy for non-cardiac chest pain. Psychol Med 1997, 27:1021-1031.
110. Cunningham C., Brown S., Kaski J.C. Effects of transcendental meditation on symptoms and electrocardiographic changes in patients with cardiac syndrome X. Am J Cardiol 2000, 85:A10. (653-655).
111. Chauhan A., Mullins P.A., Thuraisingham S.I., et al. Effect of transcutaneous electrical nerve stimulation on coronary blood flow. Circulation 1994, 89:694-702.
112. Lanza G.A., Sestito A., Sgueglia G.A., et al. Effect of spinal cord stimulation on spontaneous and stress-induced angina and "ischemia-like" ST-segment depression in patients with cardiac syndrome X. Eur Heart J 2005, 26:983-989.